logopenic progressive aphasia
logopenic progressive aphasia
Explore linked clinical trials. Standard reference: MONDO:00166448 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Targeting Language-specific and Executive-control Networks With Transcranial Direct Current Stimulation in Logopenic Variant PPA | Nerve Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, aphasia, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, language disorder, logopenic progressive aphasia, nervous system disorder, primary progressive aphasia, psychiatric disorder, speech disorder | Recruiting | Not applicable | 2026-09-09 | NCT03887481 | |
| Effects of Electrical Stimulation on Verbal Learning in Typical and Atypical Alzheimer's Disease | Alzheimer Disease, Early Onset, Alzheimer disease, brain disorder, central nervous system disorder, cognitive disorder, dementia, logopenic progressive aphasia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Active, not recruiting | Not applicable | 2026-07-15 | NCT04122001 | |
| Transcranial Magnetic Stimulation Treatment for Alzheimer's Disease | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Mild Cognitive Impairment, brain disorder, central nervous system disorder, cognitive disorder, dementia, logopenic progressive aphasia, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Early phase 1 | 2026-05-06 | NCT06538311 | |
| Transcranial Direct Current Stimulation in the Treatment of Primary Progressive Aphasia | Frontotemporal Lobar Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, aphasia, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, language disorder, logopenic progressive aphasia, metabolic disease, nervous system disorder, neurodegenerative disease, primary progressive aphasia, progressive non-fluent aphasia, proteostasis deficiencies, psychiatric disorder, speech disorder | Recruiting | Phase 2 | 2026-05-05 | NCT05386394 | |
| Intervention for Communication Quality of Life in Primary Progressive Aphasia | Aphasia, Progressive, Aphasia, Semantic, Frontotemporal Lobar Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, aphasia, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, language disorder, logopenic progressive aphasia, metabolic disease, nervous system disorder, neurodegenerative disease, primary progressive aphasia, progressive non-fluent aphasia, proteostasis deficiencies, psychiatric disorder, semantic dementia, speech disorder | Recruiting | Not applicable | 2026-04-21 | NCT07219680 | |
| Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders | Aphasia, Semantic, Frontotemporal Lobar Degeneration, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Parkinson disease, Pathological Conditions, Signs and Symptoms, Pick disease, Psychomotor Disorders, Signs and Symptoms, TDP-43 proteinopathy, aphasia, apraxia, autonomic nervous system disorder, basal ganglia disorder, behavioral variant of frontotemporal dementia, brain disorder, cardiovascular disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, hypotensive disorder, language disorder, logopenic progressive aphasia, metabolic disease, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, posterior cortical atrophy, primary dysautonomia, primary progressive aphasia, proteostasis deficiencies, psychiatric disorder, semantic dementia, speech disorder, supranuclear palsy, progressive, 1, synucleinopathy, vascular disorder | Enrolling by invitation | Not stated | 2025-11-21 | NCT04680130 | |
| Treatment for Speech and Language in Primary Progressive Aphasia | Aphasia, Progressive, Frontotemporal Lobar Degeneration, Memory Disorder, Semantic, Memory Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, aphasia, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, language disorder, logopenic progressive aphasia, metabolic disease, nervous system disorder, neurodegenerative disease, primary progressive aphasia, progressive non-fluent aphasia, proteostasis deficiencies, psychiatric disorder, semantic dementia, speech disorder | Active, not recruiting | Not applicable | 2025-11-13 | NCT04881617 | |
| Primary Progressive Aphasia Multicomponent Language Treatment Study | Aphasia, Progressive, Frontotemporal Lobar Degeneration, Memory Disorder, Semantic, Memory Disorders, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, TDP-43 proteinopathy, aphasia, brain disorder, central nervous system disorder, cognitive disorder, communication disorder, dementia, frontotemporal dementia, language disorder, logopenic progressive aphasia, metabolic disease, nervous system disorder, neurodegenerative disease, primary progressive aphasia, progressive non-fluent aphasia, proteostasis deficiencies, psychiatric disorder, semantic dementia, speech disorder | Enrolling by invitation | Not applicable | 2025-10-08 | NCT06649084 |